Resveratrol for dry eye disease - Hope or Hype?

被引:5
作者
Shetty, Rohit [1 ]
Joshi, Parth D. [2 ]
Mahendran, Krithikaa [2 ]
Jayadev, Chaitra [3 ]
Das, Debashish [2 ,4 ]
机构
[1] Narayana Nethralaya Eye Hosp, Dept Cornea & Refract Surg, Bengaluru, Karnataka, India
[2] Narayana Nethralaya, Narayana Nethralaya Fdn, Stem Cell Res Lab, GROW Lab, Bengaluru, Karnataka, India
[3] Narayana Nethralaya Eye Hosp, Dept Vitreoretina, Bengaluru, Karnataka, India
[4] Narayana Nethralaya, Narayana Nethralaya Fdn, Stem Cell Res Lab, GROW Lab, 258-A Bommasandra Ind Area, Bengaluru 560099, Karnataka, India
关键词
Cell apoptosis; dry eye disease; inflammation; oxidative stress; resveratrol; CORNEAL EPITHELIAL-CELLS; TRANS-RESVERATROL; ANTIOXIDANT ACTIVITY; NANOPARTICLES; BIOAVAILABILITY; PROLIFERATION; MITOCHONDRIAL; CYTOTOXICITY; INFLAMMATION; ACTIVATION;
D O I
10.4103/IJO.IJO_3204_22
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Dry eye disease (DED) is a multifactorial and common ophthalmic disease that has a tremendous effect on the quality of life. It is now becoming a public health concern because of our changing lifestyle and environment. The current treatment modalities, artificial tear substitutes, and anti-inflammatory therapy are directed at dry eye symptoms. One of the major drivers for DED is oxidative stress, and the polyphenol group of natural compounds has the potential to reduce the same. Resveratrol, widely found in the skin of grapes and nuts, has antioxidative and anti-inflammatory properties. It has been shown to have beneficial effects in glaucoma, age-related macular degeneration, retinopathy of prematurity, uveitis, and diabetic retinopathy. Studies have also explored the beneficial effects of resveratrol in DED, making it as a promising therapeutic molecule. Resveratrol has not yet reached clinical application because of difficulty in deliverability and low bioavailability. In this review, we explore the potential of resveratrol in DED treatment based on various in vitro and in vivo studies.
引用
收藏
页码:1270 / 1275
页数:6
相关论文
共 62 条
  • [1] Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease
    Abengozar-Vela, Antonio
    Schaumburg, Chris S.
    Stern, Michael E.
    Calonge, Margarita
    Enriquez-de-Salamanca, Amalia
    Jesus Gonzalez-Garcia, Maria
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (06) : 1023 - 1032
  • [2] Resveratrol and Ophthalmic Diseases
    Abu-Amero, Khaled K.
    Kondkar, Altaf A.
    Chalam, Kakarla V.
    [J]. NUTRIENTS, 2016, 8 (04)
  • [3] Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
    Ansari, Khalid A.
    Vavia, Pradeep R.
    Trotta, Francesco
    Cavalli, Roberta
    [J]. AAPS PHARMSCITECH, 2011, 12 (01): : 279 - 286
  • [4] Astaridewi D., 2020, Open Access Maced J Med Sci, V8, P1116, DOI [10.3889/oamjms.2020.5305, DOI 10.3889/OAMJMS.2020.5305]
  • [5] OXIDATIVE REACTIONS IN THE TEAR FLUID OF PATIENTS SUFFERING FROM DRY EYES
    AUGUSTIN, AJ
    SPITZNAS, M
    KAVIANI, N
    MELLER, D
    KOCH, FHJ
    GRUS, F
    GOBBELS, MJ
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1995, 233 (11) : 694 - 698
  • [6] TFOS DEWS II pain and sensation report
    Belmonte, Carlos
    Nichols, Jason J.
    Cox, Stephanie M.
    Brock, James A.
    Begley, Carolyn G.
    Bereiter, David A.
    Dartt, Darlene A.
    Galor, Anat
    Hamrah, Pedram
    Ivanusic, Jason J.
    Jacobs, Deborah S.
    McNamara, Nancy A.
    Rosenblatt, Mark I.
    Stapleton, Fiona
    Wolffsohn, James S.
    [J]. OCULAR SURFACE, 2017, 15 (03) : 404 - 437
  • [7] Biological effects of resveratrol
    Bhat, KPL
    Kosmeder, JW
    Pezzuto, JM
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) : 1041 - 1064
  • [8] Mechanism of human SIRT1 activation by resveratrol
    Borra, MT
    Smith, BC
    Denu, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17187 - 17195
  • [9] Assessment and management of dry eye disease
    Buckley, R. J.
    [J]. EYE, 2018, 32 (02) : 200 - 203
  • [10] Cejková J, 2008, HISTOL HISTOPATHOL, V23, P1477, DOI 10.14670/HH-23.1477